Literature DB >> 32016008

Utilizing gene expression profiles to characterize tumor infiltrating lymphocytes in cancers.

Ching-Hsuan Chen1, Tzu-Pin Lu1.   

Abstract

Entities:  

Year:  2019        PMID: 32016008      PMCID: PMC6976462          DOI: 10.21037/atm.2019.11.59

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  24 in total

1.  Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.

Authors:  Cécile Badoual; Stéphane Hans; José Rodriguez; Severine Peyrard; Christophe Klein; Nour El Houda Agueznay; Véronique Mosseri; Ollivier Laccourreye; Patrick Bruneval; Wolf H Fridman; Daniel F Brasnu; Eric Tartour
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

2.  Prognostic Impact of Tumor-Infiltrating Lymphocytes in Primary and Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.

Authors:  Joseph C Kong; Glen R Guerra; Toan Pham; Catherine Mitchell; A Craig Lynch; Satish K Warrier; Robert G Ramsay; Alexander G Heriot
Journal:  Dis Colon Rectum       Date:  2019-04       Impact factor: 4.585

3.  Validation of Human Papillomavirus as a Favourable Prognostic Marker and Analysis of CD8+ Tumour-infiltrating Lymphocytes and Other Biomarkers in Cancer of Unknown Primary in the Head and Neck Region.

Authors:  Lars Sivars; David Landin; Nathalie Grün; Andrea Vlastos; Linda Marklund; Sushma Nordemar; Torbjörn Ramqvist; Eva Munck-Wikland; Anders Näsman; Tina Dalianis
Journal:  Anticancer Res       Date:  2017-02       Impact factor: 2.480

4.  International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

Authors:  Franck Pagès; Bernhard Mlecnik; Florence Marliot; Gabriela Bindea; Fang-Shu Ou; Carlo Bifulco; Alessandro Lugli; Inti Zlobec; Tilman T Rau; Martin D Berger; Iris D Nagtegaal; Elisa Vink-Börger; Arndt Hartmann; Carol Geppert; Julie Kolwelter; Susanne Merkel; Robert Grützmann; Marc Van den Eynde; Anne Jouret-Mourin; Alex Kartheuser; Daniel Léonard; Christophe Remue; Julia Y Wang; Prashant Bavi; Michael H A Roehrl; Pamela S Ohashi; Linh T Nguyen; SeongJun Han; Heather L MacGregor; Sara Hafezi-Bakhtiari; Bradly G Wouters; Giuseppe V Masucci; Emilia K Andersson; Eva Zavadova; Michal Vocka; Jan Spacek; Lubos Petruzelka; Bohuslav Konopasek; Pavel Dundr; Helena Skalova; Kristyna Nemejcova; Gerardo Botti; Fabiana Tatangelo; Paolo Delrio; Gennaro Ciliberto; Michele Maio; Luigi Laghi; Fabio Grizzi; Tessa Fredriksen; Bénédicte Buttard; Mihaela Angelova; Angela Vasaturo; Pauline Maby; Sarah E Church; Helen K Angell; Lucie Lafontaine; Daniela Bruni; Carine El Sissy; Nacilla Haicheur; Amos Kirilovsky; Anne Berger; Christine Lagorce; Jeffrey P Meyers; Christopher Paustian; Zipei Feng; Carmen Ballesteros-Merino; Jeroen Dijkstra; Carlijn van de Water; Shannon van Lent-van Vliet; Nikki Knijn; Ana-Maria Mușină; Dragos-Viorel Scripcariu; Boryana Popivanova; Mingli Xu; Tomonobu Fujita; Shoichi Hazama; Nobuaki Suzuki; Hiroaki Nagano; Kiyotaka Okuno; Toshihiko Torigoe; Noriyuki Sato; Tomohisa Furuhata; Ichiro Takemasa; Kyogo Itoh; Prabhu S Patel; Hemangini H Vora; Birva Shah; Jayendrakumar B Patel; Kruti N Rajvik; Shashank J Pandya; Shilin N Shukla; Yili Wang; Guanjun Zhang; Yutaka Kawakami; Francesco M Marincola; Paolo A Ascierto; Daniel J Sargent; Bernard A Fox; Jérôme Galon
Journal:  Lancet       Date:  2018-05-10       Impact factor: 79.321

5.  Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations.

Authors:  Ching-Hsuan Chen; Yen-Shen Lu; Ann-Lii Cheng; Chiun-Sheng Huang; Wen-Hung Kuo; Ming-Yang Wang; Ming Chao; I-Chun Chen; Chun-Wei Kuo; Tzu-Pin Lu; Ching-Hung Lin
Journal:  Oncologist       Date:  2019-08-01

6.  Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer.

Authors:  M V Dieci; P Conte; G Bisagni; A A Brandes; A Frassoldati; L Cavanna; A Musolino; F Giotta; A Rimanti; O Garrone; E Bertone; K Cagossi; S Sarti; A Ferro; F Piacentini; A Maiorana; E Orvieto; M Sanders; F Miglietta; S Balduzzi; R D'Amico; V Guarneri
Journal:  Ann Oncol       Date:  2019-03-01       Impact factor: 32.976

7.  Histoepigenetic analysis of HPV- and tobacco-associated head and neck cancer identifies both subtype-specific and common therapeutic targets despite divergent microenvironments.

Authors:  Ivenise Carrero; Hsuan-Chen Liu; Andrew G Sikora; Aleksandar Milosavljevic
Journal:  Oncogene       Date:  2019-01-17       Impact factor: 9.867

8.  Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study.

Authors:  H Raza Ali; Leon Chlon; Paul D P Pharoah; Florian Markowetz; Carlos Caldas
Journal:  PLoS Med       Date:  2016-12-13       Impact factor: 11.069

Review 9.  Quantifying tumor-infiltrating immune cells from transcriptomics data.

Authors:  Francesca Finotello; Zlatko Trajanoski
Journal:  Cancer Immunol Immunother       Date:  2018-03-14       Impact factor: 6.968

10.  Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.

Authors:  H R Ali; E Provenzano; S-J Dawson; F M Blows; B Liu; M Shah; H M Earl; C J Poole; L Hiller; J A Dunn; S J Bowden; C Twelves; J M S Bartlett; S M A Mahmoud; E Rakha; I O Ellis; S Liu; D Gao; T O Nielsen; P D P Pharoah; C Caldas
Journal:  Ann Oncol       Date:  2014-06-09       Impact factor: 32.976

View more
  2 in total

1.  Immunogenomic Gene Signature of Cell-Death Associated Genes with Prognostic Implications in Lung Cancer.

Authors:  Pankaj Ahluwalia; Meenakshi Ahluwalia; Ashis K Mondal; Nikhil Sahajpal; Vamsi Kota; Mumtaz V Rojiani; Amyn M Rojiani; Ravindra Kolhe
Journal:  Cancers (Basel)       Date:  2021-01-05       Impact factor: 6.639

2.  Histopathological imaging features- versus molecular measurements-based cancer prognosis modeling.

Authors:  Sanguo Zhang; Yu Fan; Tingyan Zhong; Shuangge Ma
Journal:  Sci Rep       Date:  2020-09-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.